Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Minimal residual disease (MRD) is a powerful prognostic factor in acute lymphoblastic leukemia (ALL) and is used for patient stratification and treatment decisions, but its precise role in Philadelphia chromosome positive ALL is less clear. This uncertainty results largely from methodological differ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pfeifer, Heike (VerfasserIn) , Cazzaniga, G. (VerfasserIn) , Velden, V. H. J. van der (VerfasserIn) , Cayuela, J. M. (VerfasserIn) , Schäfer, B. (VerfasserIn) , Spinelli, O. (VerfasserIn) , Akiki, S. (VerfasserIn) , Avigad, S. (VerfasserIn) , Bendit, I. (VerfasserIn) , Borg, K. (VerfasserIn) , Cavé, H. (VerfasserIn) , Elia, L. (VerfasserIn) , Reshmi, S. C. (VerfasserIn) , Gerrard, G. (VerfasserIn) , Hayette, S. (VerfasserIn) , Hermanson, M. (VerfasserIn) , Juh, A. (VerfasserIn) , Jurcek, T. (VerfasserIn) , Chillón, M. C. (VerfasserIn) , Homburg, C. (VerfasserIn) , Martinelli, G. (VerfasserIn) , Kairisto, V. (VerfasserIn) , Lange, T. (VerfasserIn) , Lion, T. (VerfasserIn) , Müller, Martin Christian (VerfasserIn) , Pane, F. (VerfasserIn) , Rai, L. (VerfasserIn) , Damm-Welk, C. (VerfasserIn) , Sacha, T. (VerfasserIn) , Schnittger, S. (VerfasserIn) , Touloumenidou, T. (VerfasserIn) , Valerhaugen, H. (VerfasserIn) , Vandenberghe, P. (VerfasserIn) , Zuna, J. (VerfasserIn) , Serve, H. (VerfasserIn) , Herrmann, E. (VerfasserIn) , Markovic, S. (VerfasserIn) , Dongen, J. J. M. van (VerfasserIn) , Ottmann, O. G. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 11 March 2019
In: Leukemia
Year: 2019, Jahrgang: 33, Heft: 8, Pages: 1910-1922
ISSN:1476-5551
DOI:10.1038/s41375-019-0413-0
Online-Zugang:Verlag, Volltext: https://doi.org/10.1038/s41375-019-0413-0
Verlag, Volltext: https://www.nature.com/articles/s41375-019-0413-0
Volltext
Verfasserangaben:H. Pfeifer, G. Cazzaniga, V.H.J. van der Velden, J.M. Cayuela, B. Schäfer, O. Spinelli, S. Akiki, S. Avigad, I. Bendit, K. Borg, H. Cavé, L. Elia, S.C. Reshmi, G. Gerrard, S. Hayette, M. Hermanson, A. Juh, T. Jurcek, M.C. Chillón, C. Homburg, G. Martinelli, V. Kairisto, T. Lange, T. Lion, M.C. Mueller, F. Pane, L. Rai, C. Damm-Welk, T. Sacha, S. Schnittger, T. Touloumenidou, H. Valerhaugen, P. Vandenberghe, J. Zuna, H. Serve, E. Herrmann, S. Markovic, J.J.M. van Dongen, O.G. Ottmann

MARC

LEADER 00000caa a2200000 c 4500
001 1698722893
003 DE-627
005 20240306135342.0
007 cr uuu---uuuuu
008 200525s2019 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41375-019-0413-0  |2 doi 
035 |a (DE-627)1698722893 
035 |a (DE-599)KXP1698722893 
035 |a (OCoLC)1341326312 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pfeifer, Heike  |e VerfasserIn  |0 (DE-588)121086777X  |0 (DE-627)1698722591  |4 aut 
245 1 0 |a Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1  |c H. Pfeifer, G. Cazzaniga, V.H.J. van der Velden, J.M. Cayuela, B. Schäfer, O. Spinelli, S. Akiki, S. Avigad, I. Bendit, K. Borg, H. Cavé, L. Elia, S.C. Reshmi, G. Gerrard, S. Hayette, M. Hermanson, A. Juh, T. Jurcek, M.C. Chillón, C. Homburg, G. Martinelli, V. Kairisto, T. Lange, T. Lion, M.C. Mueller, F. Pane, L. Rai, C. Damm-Welk, T. Sacha, S. Schnittger, T. Touloumenidou, H. Valerhaugen, P. Vandenberghe, J. Zuna, H. Serve, E. Herrmann, S. Markovic, J.J.M. van Dongen, O.G. Ottmann 
264 1 |c 11 March 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 11 March 2019 
500 |a Gesehen am 25.05.2020 
520 |a Minimal residual disease (MRD) is a powerful prognostic factor in acute lymphoblastic leukemia (ALL) and is used for patient stratification and treatment decisions, but its precise role in Philadelphia chromosome positive ALL is less clear. This uncertainty results largely from methodological differences relating to the use of real-time quantitative PCR (qRT-PCR) to measure BCR-ABL1 transcript levels for MRD analysis. We here describe the first results by the EURO-MRD consortium on standardization of qRT-PCR for the e1a2 BCR-ABL1 transcript in Ph + ALL, designed to overcome the lack of standardisation of laboratory procedures and data interpretation. Standardised use of EAC primer/probe sets and of centrally prepared plasmid standards had the greatest impact on reducing interlaboratory variability. In QC1 the proportion of analyses with BCR-ABL1/ABL1 ratios within half a log difference were 40/67 (60%) and 52/67 (78%) at 10−3 and 36/67 (53%) and 53/67 (79%) at 10−4BCR-ABL1/ABL1. Standardized RNA extraction, cDNA synthesis and cycler platforms did not improve results further, whereas stringent application of technical criteria for assay quality and uniform criteria for data interpretation and reporting were essential. We provide detailed laboratory recommendations for the standardized MRD analysis in routine diagnostic settings and in multicenter clinical trials for Ph + ALL. 
700 1 |a Cazzaniga, G.  |e VerfasserIn  |4 aut 
700 1 |a Velden, V. H. J. van der  |e VerfasserIn  |4 aut 
700 1 |a Cayuela, J. M.  |e VerfasserIn  |4 aut 
700 1 |a Schäfer, B.  |e VerfasserIn  |4 aut 
700 1 |a Spinelli, O.  |e VerfasserIn  |4 aut 
700 1 |a Akiki, S.  |e VerfasserIn  |4 aut 
700 1 |a Avigad, S.  |e VerfasserIn  |4 aut 
700 1 |a Bendit, I.  |e VerfasserIn  |4 aut 
700 1 |a Borg, K.  |e VerfasserIn  |4 aut 
700 1 |a Cavé, H.  |e VerfasserIn  |4 aut 
700 1 |a Elia, L.  |e VerfasserIn  |4 aut 
700 1 |a Reshmi, S. C.  |e VerfasserIn  |4 aut 
700 1 |a Gerrard, G.  |e VerfasserIn  |4 aut 
700 1 |a Hayette, S.  |e VerfasserIn  |4 aut 
700 1 |a Hermanson, M.  |e VerfasserIn  |4 aut 
700 1 |a Juh, A.  |e VerfasserIn  |4 aut 
700 1 |a Jurcek, T.  |e VerfasserIn  |4 aut 
700 1 |a Chillón, M. C.  |e VerfasserIn  |4 aut 
700 1 |a Homburg, C.  |e VerfasserIn  |4 aut 
700 1 |a Martinelli, G.  |e VerfasserIn  |4 aut 
700 1 |a Kairisto, V.  |e VerfasserIn  |4 aut 
700 1 |a Lange, T.  |e VerfasserIn  |4 aut 
700 1 |a Lion, T.  |e VerfasserIn  |4 aut 
700 1 |a Müller, Martin Christian  |d 1972-  |e VerfasserIn  |0 (DE-588)121360296  |0 (DE-627)705409236  |0 (DE-576)181482819  |4 aut 
700 1 |a Pane, F.  |e VerfasserIn  |4 aut 
700 1 |a Rai, L.  |e VerfasserIn  |4 aut 
700 1 |a Damm-Welk, C.  |e VerfasserIn  |4 aut 
700 1 |a Sacha, T.  |e VerfasserIn  |4 aut 
700 1 |a Schnittger, S.  |e VerfasserIn  |4 aut 
700 1 |a Touloumenidou, T.  |e VerfasserIn  |4 aut 
700 1 |a Valerhaugen, H.  |e VerfasserIn  |4 aut 
700 1 |a Vandenberghe, P.  |e VerfasserIn  |4 aut 
700 1 |a Zuna, J.  |e VerfasserIn  |4 aut 
700 1 |a Serve, H.  |e VerfasserIn  |4 aut 
700 1 |a Herrmann, E.  |e VerfasserIn  |4 aut 
700 1 |a Markovic, S.  |e VerfasserIn  |4 aut 
700 1 |a Dongen, J. J. M. van  |e VerfasserIn  |4 aut 
700 1 |a Ottmann, O. G.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 33(2019), 8, Seite 1910-1922  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 
773 1 8 |g volume:33  |g year:2019  |g number:8  |g pages:1910-1922  |g extent:13  |a Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 
856 4 0 |u https://doi.org/10.1038/s41375-019-0413-0  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41375-019-0413-0  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200525 
993 |a Article 
994 |a 2019 
998 |g 121360296  |a Müller, Martin Christian  |m 121360296:Müller, Martin Christian  |d 60000  |d 61200  |e 60000PM121360296  |e 61200PM121360296  |k 0/60000/  |k 1/60000/61200/  |p 25 
999 |a KXP-PPN1698722893  |e 3670640630 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1038/s41375-019-0413-0"],"eki":["1698722893"]},"origin":[{"dateIssuedDisp":"11 March 2019","dateIssuedKey":"2019"}],"name":{"displayForm":["H. Pfeifer, G. Cazzaniga, V.H.J. van der Velden, J.M. Cayuela, B. Schäfer, O. Spinelli, S. Akiki, S. Avigad, I. Bendit, K. Borg, H. Cavé, L. Elia, S.C. Reshmi, G. Gerrard, S. Hayette, M. Hermanson, A. Juh, T. Jurcek, M.C. Chillón, C. Homburg, G. Martinelli, V. Kairisto, T. Lange, T. Lion, M.C. Mueller, F. Pane, L. Rai, C. Damm-Welk, T. Sacha, S. Schnittger, T. Touloumenidou, H. Valerhaugen, P. Vandenberghe, J. Zuna, H. Serve, E. Herrmann, S. Markovic, J.J.M. van Dongen, O.G. Ottmann"]},"relHost":[{"recId":"32046699X","language":["eng"],"note":["Gesehen am 15.03.04"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1Leukemia","part":{"year":"2019","pages":"1910-1922","issue":"8","text":"33(2019), 8, Seite 1910-1922","volume":"33","extent":"13"},"pubHistory":["Nachgewiesen 11.1997 -"],"title":[{"title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"origin":[{"dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}]}],"physDesc":[{"extent":"13 S."}],"title":[{"title_sort":"Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1","title":"Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1"}],"person":[{"given":"Heike","family":"Pfeifer","role":"aut","roleDisplay":"VerfasserIn","display":"Pfeifer, Heike"},{"role":"aut","display":"Cazzaniga, G.","roleDisplay":"VerfasserIn","given":"G.","family":"Cazzaniga"},{"given":"V. H. J. van der","family":"Velden","role":"aut","roleDisplay":"VerfasserIn","display":"Velden, V. H. J. van der"},{"given":"J. M.","family":"Cayuela","role":"aut","roleDisplay":"VerfasserIn","display":"Cayuela, J. M."},{"family":"Schäfer","given":"B.","roleDisplay":"VerfasserIn","display":"Schäfer, B.","role":"aut"},{"family":"Spinelli","given":"O.","display":"Spinelli, O.","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Akiki, S.","roleDisplay":"VerfasserIn","role":"aut","family":"Akiki","given":"S."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Avigad, S.","given":"S.","family":"Avigad"},{"roleDisplay":"VerfasserIn","display":"Bendit, I.","role":"aut","family":"Bendit","given":"I."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Borg, K.","given":"K.","family":"Borg"},{"family":"Cavé","given":"H.","roleDisplay":"VerfasserIn","display":"Cavé, H.","role":"aut"},{"role":"aut","display":"Elia, L.","roleDisplay":"VerfasserIn","given":"L.","family":"Elia"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Reshmi, S. C.","given":"S. C.","family":"Reshmi"},{"given":"G.","family":"Gerrard","role":"aut","roleDisplay":"VerfasserIn","display":"Gerrard, G."},{"roleDisplay":"VerfasserIn","display":"Hayette, S.","role":"aut","family":"Hayette","given":"S."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Hermanson, M.","given":"M.","family":"Hermanson"},{"given":"A.","family":"Juh","role":"aut","display":"Juh, A.","roleDisplay":"VerfasserIn"},{"family":"Jurcek","given":"T.","display":"Jurcek, T.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Chillón, M. C.","roleDisplay":"VerfasserIn","given":"M. C.","family":"Chillón"},{"family":"Homburg","given":"C.","display":"Homburg, C.","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Martinelli, G.","roleDisplay":"VerfasserIn","role":"aut","family":"Martinelli","given":"G."},{"given":"V.","family":"Kairisto","role":"aut","display":"Kairisto, V.","roleDisplay":"VerfasserIn"},{"family":"Lange","given":"T.","roleDisplay":"VerfasserIn","display":"Lange, T.","role":"aut"},{"family":"Lion","given":"T.","display":"Lion, T.","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Müller, Martin Christian","roleDisplay":"VerfasserIn","role":"aut","family":"Müller","given":"Martin Christian"},{"role":"aut","display":"Pane, F.","roleDisplay":"VerfasserIn","given":"F.","family":"Pane"},{"given":"L.","family":"Rai","role":"aut","roleDisplay":"VerfasserIn","display":"Rai, L."},{"given":"C.","family":"Damm-Welk","role":"aut","display":"Damm-Welk, C.","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Sacha, T.","role":"aut","family":"Sacha","given":"T."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Schnittger, S.","given":"S.","family":"Schnittger"},{"roleDisplay":"VerfasserIn","display":"Touloumenidou, T.","role":"aut","family":"Touloumenidou","given":"T."},{"family":"Valerhaugen","given":"H.","display":"Valerhaugen, H.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Vandenberghe, P.","roleDisplay":"VerfasserIn","given":"P.","family":"Vandenberghe"},{"given":"J.","family":"Zuna","role":"aut","roleDisplay":"VerfasserIn","display":"Zuna, J."},{"given":"H.","family":"Serve","role":"aut","display":"Serve, H.","roleDisplay":"VerfasserIn"},{"family":"Herrmann","given":"E.","display":"Herrmann, E.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Markovic, S.","roleDisplay":"VerfasserIn","given":"S.","family":"Markovic"},{"roleDisplay":"VerfasserIn","display":"Dongen, J. J. M. van","role":"aut","family":"Dongen","given":"J. J. M. van"},{"display":"Ottmann, O. G.","roleDisplay":"VerfasserIn","role":"aut","family":"Ottmann","given":"O. G."}],"recId":"1698722893","language":["eng"],"note":["Published online: 11 March 2019","Gesehen am 25.05.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a PFEIFERHEISTANDARDIS1120